NIO
NIO Inc.
NIO has a slight edge over TXRH overall, supported by stronger fundamentals and stronger valuation.
TXRH
Texas Roadhouse, Inc.
TXRH has lower modeled downside risk, despite its lower overall score.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
TXRH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
TXRH's revenue, profitability, cash flow and balance sheet are all currently healthy.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
TXRH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $158 | -15% |
| Fair | 28x | $177 | -4.7% |
| Current | 29x | $186 | — |
| Expensive | 34x | $219 | +18% |
Historical ranges are pointers, not guarantees.
TXRH's PE is in its fair range at 29x.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
TXRH Forward outlook
There aren't enough analyst estimates for TXRH to show an outlook.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
TXRH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $6.37 | -2.6% |
| Q2 2026 | $6.26 | -4.4% |
| Q1 2026 | $6.27 | -3.2% |
| Q4 2025 | $6.10 | -5.7% |
| Q3 2025 | $6.54 | +12% |
| Q2 2025 | $6.55 | +19% |
| Q1 2025 | $6.48 | +31% |
| Q4 2024 | $6.47 | +43% |
TXRH has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO's revenue has grown year over year for seven quarters in a row: $4.8B last quarter, up 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
TXRH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +9.5% |
| Q2 2026 | $1.7B | +11% |
| Q1 2026 | $1.6B | +13% |
| Q4 2025 | $1.5B | +3.1% |
| Q3 2025 | $1.4B | +13% |
| Q2 2025 | $1.5B | +13% |
| Q1 2025 | $1.4B | +9.6% |
| Q4 2024 | $1.4B | +23% |
TXRH's revenue has grown year over year for 23 quarters in a row: $1.6B last quarter, up 9.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.5% | -0.2 points |
| Q2 2026 | 8.5% | -1.2 points |
| Q1 2026 | 9% | -0.3 points |
| Q4 2025 | 6.5% | -3.1 points |
| Q3 2025 | 6.8% | -1.3 points |
| Q2 2025 | 9.7% | -1 points |
| Q1 2025 | 9.3% | -0.8 points |
| Q4 2024 | 9.6% | +2.5 points |
TXRH has the edge over NIO on profitability, with a higher operating margin.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
TXRH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | -25% |
| Q2 2026 | $81.5M | +128% |
| Q1 2026 | $178.9M | +12% |
| Q4 2025 | $131.3M | +1.2% |
| Q3 2025 | $14.7M | -69% |
| Q2 2025 | $35.7M | -36% |
| Q1 2025 | $160.4M | -3.3% |
| Q4 2024 | $129.7M | +82% |
TXRH generated $403M in free cash flow over the past year, up 18% from the year before.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TXRH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
TXRH has more cash than debt.
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
TXRH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 47.9 | Neutral |
TXRH's weekly RSI is 54 (neutral) and its Stochastic is 48 (neutral).
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
TXRH PE vs Consumer Cyclical Sector
| Metric | TXRH | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 62% above |
| PE % | 58 | 47 | 11 pts above |
TXRH is trading at 29x earnings, a 62% premium to the Consumer Cyclical sector's median of 18x.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
TXRH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $170.5 | 9.1% above |
| 20 week MA | $185.0 | 0.5% above |
| 50 week MA | $178.9 | 4% above |
| 100 week MA | $177.4 | 4.8% above |
| 200 week MA | $156.4 | 19% above |
TXRH has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.
TXRH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $55.0 | $80.0 | +45% |
| 2021 | $80.0 | $88.8 | +11% |
| 2022 | $88.8 | $96.3 | +8.5% |
| 2023 | $96.3 | $122.2 | +27% |
| 2024 | $122.2 | $181.9 | +49% |
| 2025 | $181.9 | $170.8 | -6.1% |
| 2026 YTD | $170.8 | $186.0 | +8.9% |
TXRH has the edge over NIO on returns for 2026, with the stronger performance.